Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+CD4+T Cells Promotes Akt and ERK Activation and Costimulates IFN-γ Production-Reference-Cited by-同舟云学术

Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+CD4+T Cells Promotes Akt and ERK Activation and Costimulates IFN-γ Production

Published:2009-12-11 Issue:2 Volume:184 Page:545-549
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Basu Aninda,Hoerning Andre,Datta Dipak,Edelbauer Monika,Stack Maria P.,Calzadilla Katiana,Pal Soumitro,Briscoe David M.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference20 articles.

1. Angiogenesis in cancer, vascular, rheumatoid and other disease

2. Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity

3. Function of the Vascular Endothelial Growth Factor Receptors Flt-1 and Flk-1/KDR in the Alloimmune Response In Vivo

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

3. Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer;International Immunopharmacology;2024-03

4. The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma;International Journal of Molecular Sciences;2023-12-31

5. Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study;Cancer Immunology, Immunotherapy;2023-05-29